Skip to main content

All Access Subscription

Get unlimited access to our full publication and article library.

Get Access Now

Interested in Group Sales? Learn more

<p>The FDA has issued a proposed rule that some say would provide research institutions with much-needed clarity on informed consent regulations and open the door to clinical breakthroughs.</p>

Informed Consent Rule Changes Could Help IRBs, Expand Research

But do FDA’s proposed consent waivers go far enough?